Half of Hypothyroid Patients Show Early TSH Improvement with Homeopathy: Clinic Data
Bengaluru, January 20, 2026: More than half of hypothyroid patients recorded early improvement in thyroid function after beginning homeopathic treatment, according to an internal analysis released by Dr Kalyan Banerjee’s Clinic. The findings are drawn from treatment outcomes of over 1,200 patients managed at the clinic.
Sharing the data, Dr Kushal Banerjee, Senior Homeopath, said 52% of patients showed a reduction in TSH (Thyroid Stimulating Hormone) levels at their first follow-up. “This suggests homeopathy may play a role in managing hypothyroidism, particularly when intervention begins at an early stage,” he noted. In urban settings, thyroid disorders are often detected early due to increased testing. “Many such patients are able to delay or avoid starting hormone replacement therapy. Those already on medication may, in some cases, gradually reduce dosage under medical supervision,” Dr Banerjee said.
Doctors at the clinic also observed that patients with fluctuating thyroid readings—often subjected to repeated dose changes—respond better when treatment focuses on stabilisation rather than frequent adjustments.
Hypothyroidism affects an estimated 42 million Indians, with women between 15 and 49 years at higher risk. While iodine deficiency is no longer a major concern, clinicians report a rise in autoimmune conditions such as Hashimoto’s thyroiditis.
With thyroid testing becoming widespread, experts caution against premature lifelong medication. “Clear guidelines, better awareness and balanced treatment decisions are essential to address India’s growing thyroid burden,” Dr Banerjee said.
Steroid Misuse Emerging as a Key Trigger for Secondary Glaucoma, Say Doctors
Bengaluru | January 20, 2026: Doctors across India have raised serious concern over the growing and often unsupervised use of steroid medications, warning that it is fast emerging as a significant cause of secondary glaucoma — a sight-threatening eye disease that can lead to irreversible blindness if left undetected.
Steroids, commonly prescribed or self-administered for allergies, skin disorders, respiratory conditions and even used as over-the-counter eye drops, are known to elevate intraocular pressure when used over prolonged periods. Experts caution that this pressure build-up often goes unnoticed by patients, silently damaging the optic nerve over time.
India already carries a substantial glaucoma burden, with an estimated 12–13 million people affected — nearly one-sixth of the global total. Worldwide, glaucoma impacts approximately 75–80 million individuals, a figure projected to exceed 110 million by 2040. Despite being the leading cause of irreversible blindness globally, glaucoma remains grossly underdiagnosed in India.
Doctors highlight that nearly 85–90 per cent of glaucoma cases in the country go undetected. Since the disease progresses without early symptoms, patients often seek medical attention only after significant and permanent vision loss has occurred, resulting in avoidable disability and socioeconomic consequences.
“We are witnessing a clear increase in steroid-induced glaucoma, particularly among patients using steroid eye drops or medications without medical supervision,” said Dr Sandhya ES, Consultant Ophthalmologist, Dr Agarwals Eye Hospital, Bengaluru. “The danger lies in the absence of early symptoms — patients feel normal even as eye pressure rises steadily, causing irreversible optic nerve damage,” she added.
Over the past two to three years, ophthalmologists have reported a steady rise in diagnosed glaucoma cases, attributed to an ageing population, increasing rates of diabetes and myopia, better diagnostic tools and growing awareness. However, specialists warn that a significant proportion of new cases are now linked to secondary glaucoma caused by prolonged or inappropriate steroid use — a largely preventable risk with timely screening and guidance.
Glaucoma is most commonly detected in individuals over 40, with peak incidence between 50 and 70 years. That said, doctors are increasingly identifying juvenile and early-onset cases, particularly among those with a family history or secondary risk factors. Primary open-angle glaucoma remains the most common form, followed by angle-closure glaucoma, with steroid-induced and pseudoexfoliation glaucoma also frequently seen in clinical practice.
“Early warning signs such as peripheral vision loss, frequent changes in spectacle power or seeing halos around lights are often ignored,” Dr Sandhya noted. “Since central vision remains intact initially, diagnosis is frequently delayed.”
Experts also cautioned against common misconceptions — including the belief that good vision equals healthy eyes, that glaucoma affects only the elderly, or that normal eye pressure rules out the disease. Individuals with diabetes, hypertension, thyroid disorders, high myopia, long-term steroid use, or a history of eye injury, including childhood trauma, are considered high-risk and advised regular eye examinations.
As part of Glaucoma Awareness Month, doctors emphasised the importance of routine comprehensive eye check-ups. Those above 40 years are advised screening every one to two years, while high-risk individuals should undergo annual evaluations. Vision testing alone is insufficient without assessment of eye pressure and optic nerve health. To promote early detection, Dr Agarwals Eye Hospital is offering a free glaucoma work-up for diabetic patients across India as part of its awareness initiative. The offer is valid until February 15, 2026. Appointments can be booked by calling 95949 01868.
Rainmatter by Zerodha Invests in PolyCycl to Scale Chemical Recycling of Plastics
Bengaluru, January 20, 2026:PolyCycl, a Chandigarh-based deep-tech startup working on chemical recycling of waste plastics, has secured Series A funding from Rainmatter, the climate-focused investment arm of Zerodha. The investment will help PolyCycl scale its proprietary technology aimed at enabling plastic-to-plastic circularity, particularly for hard-to-recycle plastic waste.
PolyCycl has spent over a decade developing a fully continuous chemical recycling platform that converts low-grade plastics, including single-use polythene bags, into liquid hydrocarbon oils through a patented, cost-efficient process. These outputs are further purified using the company’s in-house systems and supplied to petrochemical and oil and gas companies, where they are used as feedstock to manufacture low-carbon products, including food-grade virgin plastics.
The Rainmatter investment is part of PolyCycl’s phased and fiscally disciplined capitalisation strategy, largely driven by founder funding and select strategic investors. It follows the rollout of PolyCycl’s Generation VI technology platform in 2025, which has undergone extended continuous operations and pre-qualification by major petrochemical companies. The platform has demonstrated Technology Readiness Level 7, indicating industrial-scale viability and readiness for wider deployment.
Commenting on the investment, Amit Tandon, Founder and CEO of PolyCycl, said chemical recycling requires deep engineering and long-term commitment. “Our priority has been to build robust technology that works reliably at industrial scale and integrates seamlessly into petrochemical value chains. Rainmatter’s support will help us move from proven technology to broader commercial adoption,” he said.
Nithin Kamath, Founder of Zerodha and Rainmatter, said addressing plastic waste requires sustained, long-term solutions. “The plastics end-of-life problem needs serious innovation. PolyCycl is tackling this challenge through technology, and we are excited to support their journey,” he said. Abhinav Singh Negi, who leads business and investments at Rainmatter, said PolyCycl stood out for its engineering depth and long-term vision. “Technologies like this have the potential to reshape entire sectors. PolyCycl’s platform is well-positioned for both domestic deployment and global licensing, enabling credible circularity at scale,” he noted.
PolyCycl plans to use the funds to accelerate commercial deployments with industrial partners, strengthen engineering and operational teams, and support domestic and international scale-up and licensing. The company will also deepen collaboration with petrochemical and downstream manufacturing partners.
Akino by Trendsquares Announces Sankranthi Festive Offer in East Bengaluru
Bengaluru, January 19, 2026: Marking the festive spirit of Sankranthi, a season traditionally associated with prosperity and new beginnings, Trendsquares has unveiled a limited-period benefit for its premium residential project, Akino, located at Panathur in East Bengaluru.
As part of the festive offer, homes at Trendsquares Akino are being offered at a special price of ₹11,000 per sq. ft., with an additional benefit of ₹500 per sq. ft. for bookings made during the Sankranthi period. The initiative is aimed at homebuyers seeking a well-timed and meaningful investment during the auspicious season.
Akino is a RERA-approved project (RERA No: PRM/KA/RERA/1251/446/PR/130325/007619), reflecting Trendsquares’ commitment to transparency, regulatory compliance, and customer trust. Spread across 4.75 acres, the development features 418 spacious 3 and 4 BHK apartments across three towers of 18 storeys each. Nestled beside a lake and forested landscape, the project offers uninterrupted views of nature—an increasingly rare feature in East Bengaluru’s rapidly developing corridor.
Designed as a modern, nature-centric lifescape, Akino combines peaceful surroundings with contemporary living. The project offers smart home-enabled residences, a 22,000+ sq. ft. fully equipped clubhouse, landscaped gardens, wellness zones, and thoughtfully designed outdoor amenities that encourage community living and everyday well-being.
Announcing the festive benefit, R. Rajasekhar Reddy, Managing Director, Trendsquares, said Sankranthi represents optimism and forward-looking decisions for families. He added that Akino has been envisioned as a future-ready living space that blends nature, comfort, and thoughtful planning, and the festive offer is intended to make premium living more accessible to discerning homebuyers.
Strategically located in Panathur, Akino enjoys excellent connectivity to Whitefield, Outer Ring Road, and key IT hubs. The project is also surrounded by established social infrastructure such as reputed schools, hospitals, retail centres, and upcoming metro connectivity, making it attractive for both end-users and long-term investors.
With its Sankranthi-exclusive pricing, strong location advantage, and focus on nature-led, smart living, Trendsquares Akino offers a compelling opportunity for homebuyers in East Bengaluru.
Grand Annual Day Celebrated at Greenwood School, Hosakerehalli
Bengaluru: Greenwood School, Hosakerehalli, celebrated its Grand Annual Day with great enthusiasm at the Kempegowda Playground. The event was formally inaugurated by noted actor and producer Dr. Gandasi Sadananda Swamy, who lit the ceremonial lamp.
The celebration was graced by special guests Yogita Prakash and Maithri G., adding prestige to the occasion. Several dignitaries were present, including School Principal Maria Nancy, School President Eugene Bastin, Coordinator Rita, CIS Scouts IPO Officer Deepika, Headmistress Mangalagowri, and Mukunda Prasad Gandhi.
A key highlight of the programme was the felicitation of students who achieved the highest academic scores during the 2024–25 academic year. The award ceremony recognized their dedication, hard work, and outstanding performance, inspiring fellow students to strive for excellence.
The event showcased the school’s commitment to holistic education and concluded on a celebratory note with active participation from students, staff, and parents.
City Today News 
You must be logged in to post a comment.